Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Ziprasidone Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,605Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report for Week of June 28, 2023
    Enforcement Report for Week of June 28, 2023

    28 Jun 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-for-week-of-june-28-2023-96236.pdf

    FDA
    28 Jun 2023
    Share Share
    The Harvard Drug Group, LLC Issues Voluntary Nationwide Recall of Dronabinol Capsules, USP, 2.5 mg and Ziprasidone Hydrochloride Capsules, 20 mg Due to Label Mix-up
    The Harvard Drug Group, LLC Issues Voluntary Nationwide Recall of Dronabinol Capsules, USP, 2.5 mg and Ziprasidone Hydrochloride Capsules, 20 mg Due to Label Mix-up

    14 Jun 2023

    // FDA

    https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/harvard-drug-group-llc-issues-voluntary-nationwide-recall-dronabinol-capsules-usp-25-mg-and

    FDA
    14 Jun 2023
    Share Share
    Zydus Pharm’s Generic Ziprasidone Hydrochloride Receives Approval In US
    Zydus Pharm’s Generic Ziprasidone Hydrochloride Receives Approval In US

    25 Aug 2017

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208988

    FDA
    25 Aug 2017
    Share Share
    Aurobindo's Generic Ziprasidone Hydrochloride Receives Approval In US
    Aurobindo's Generic Ziprasidone Hydrochloride Receives Approval In US

    27 Dec 2016

    // FDA

    http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204117

    FDA
    27 Dec 2016
    Share Share
    US FDA warns Pfizer antipsychotic linked to serious allergic reaction
    US FDA warns Pfizer antipsychotic linked to serious allergic reaction

    16 Dec 2014

    // REUTERS

    https://www.reuters.com/article/pfizer-fda-antipsychotic/fda-warns-pfizers-antipsychotic-could-cause-fatal-skin-reaction-idUSL3N0TV4MH20141211

    REUTERS
    16 Dec 2014
    Share Share
    FDA Drug Safety Communication: FDA Reporting Mental Health Drug Ziprasidone (Geodon) Associated with Rare but Potentially Fatal Skin Reactions
    FDA Drug Safety Communication: FDA Reporting Mental Health Drug Ziprasidone (Geodon) Associated with Rare but Potentially Fatal Skin Reactions

    11 Dec 2014

    // Press Release EIN Newsdesk

    http://pharmaceuticals.einnews.com/pr_news/239287157/ziprasidone-marketed-as-geodon-and-generics-drug-safety-communication-rare-but-potentially-fatal-skin-reactions

    Press Release EIN Newsdesk
    11 Dec 2014
    Share Share